KKR-backed Univercells Technologies acquired by Donaldson Company

Univercells a provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this